Northern Trust’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-69,029
| Closed | -$9.66K | – | 4500 |
|
|
2024
Q1 | $9.66K | Hold |
69,029
| – | – | ﹤0.01% | 4390 |
|
|
2023
Q4 | $10K | Hold |
69,029
| – | – | ﹤0.01% | 4419 |
|
|
2023
Q3 | $12.1K | Hold |
69,029
| – | – | ﹤0.01% | 4386 |
|
|
2023
Q2 | $215K | Buy |
69,029
+39,763
| +136% | +$118K | ﹤0.01% | 3800 |
|
|
2023
Q1 | $74.9K | Hold |
29,266
| – | – | ﹤0.01% | 4155 |
|
|
2022
Q4 | $43.6K | Hold |
29,266
| – | – | ﹤0.01% | 4311 |
|
|
2022
Q3 | $51K | Buy |
29,266
+11,091
| +61% | +$15.7K | ﹤0.01% | 4319 |
|
|
2022
Q2 | $24K | Hold |
18,175
| – | – | ﹤0.01% | 4596 |
|
|
2022
Q1 | $43K | Hold |
18,175
| – | – | ﹤0.01% | 4566 |
|
|
2021
Q4 | $83K | Hold |
18,175
| – | – | ﹤0.01% | 4475 |
|
|
2021
Q3 | $147K | Buy |
18,175
+3,380
| +23% | +$29K | ﹤0.01% | 4294 |
|
|
2021
Q2 | $145K | Sell |
14,795
-80,150
| -84% | -$651K | ﹤0.01% | 4263 |
|
|
2021
Q1 | $838K | Sell |
94,945
-3,818
| -4% | -$41.9K | ﹤0.01% | 3653 |
|
|
2020
Q4 | $1.01M | Sell |
98,763
-5,182
| -5% | -$56.7K | ﹤0.01% | 3517 |
|
|
2020
Q3 | $940K | Sell |
103,945
-240
| -0.2% | -$1.9K | ﹤0.01% | 3417 |
|
|
2020
Q2 | $744K | Buy |
104,185
+70,774
| +212% | +$751K | ﹤0.01% | 3457 |
|
|
2020
Q1 | $317K | Buy |
33,411
+441
| +1% | +$5.68K | ﹤0.01% | 3559 |
|
|
2019
Q4 | $434K | Buy |
+32,970
| New | +$402K | ﹤0.01% | 3592 |
|
Other funds holding GRTX
Northern Trust's GRTX Position: Q2 2024 in Review
Northern Trust sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 69,029 shares — an estimated $9.66K sold.
Northern Trust first reported a position in GRTX in Q4 2019 and held it in 18 quarters. The position peaked at $1.01M in Q4 2020. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.
- Northern Trust reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Northern Trust sold 69,029 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $9.66K.
- Northern Trust first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 18 quarters.
- Northern Trust's Galera Therapeutics, Inc. Common Stock position peaked at $1.01M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.
Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.